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ABSTRAK 
SERANGAN JANTlTNG AKUT: SATlT KAJIA_N JANGKAMASA 
DA_"R.I PINTlT KEJA-.RlTM. 
OBJEKTIF 
Tujuan utama kajian ini adalah untuk menunjukkan kemungkinan untuk 
memu1akan penggunaan Streptokinase di-dalam rawatan serangan jantung akut di 
Jabatan Kecemasan Hospital Kuala Lumpur dan juga hospital-hospital lain di 
negara ini. Tujuan kedua kajian ini pula, ialah ingin menunjukkan masa yan.g 
diambil untuk rawatan ini adalah lebih singkat sekiranya kita memulakan rawatan 
ini di jabatan kecemasan berbanding jika rawatan ini bermula di wad rawatan 
jantung, dan yang ketiga, untuk menunjukan masa yang diambil sema.kin singka.t 
apabila kakitangan jabatan kecemasan sudah mempunyai pengalaman dengan cara 
rawatan ini .. 
KAEDAH 
Kajian ini telah dibuat pada tahun 1997, apabila semua pesakit dikenalpasti 
mengidap penyakit serangan jantung akut dirawat dengan menggunakan 
Streptokinase, di Jabatan Kecemasan Hospital Kuala Lumpur. Pada tahun 1997, 
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kami telah merawat seramai 67 orang pesakit dan pada tahun 1998 kami teiah 
merawat seramai 66 orang pesakit sehingga bulan Julai sahaja. 
Masa yang diambil untuk tnemulakan rawatan Streptokinase dikira bermuia 
dari masa pendaftaran semua pesakit di jabatan kecemasan sehingga kami 
memulakan Streptokinase. Semua nama pesakit telah direkod oleh jururawat-
jururawat di dalam buku pendaftaran khas. Semua kes- kes ini dirawat di zon 
kritikal jabatan kecemasan Hospital Kuala Lumpur sebelum dihantar ke wad 
rawatan jantung di tingkat empat. Selain merekod masa yang diambil, kami juga 
telah merekod nama, bangsa, jantina, dan umur para pesakit. Kami juga telah 
merekod komplikasi-komplikasi kaedah Streptokinase di jabatan kecemasan dan 
juga wad rawatanjantung (CCU). 
Data tersebut telah dianalisa menggunak:an ujian Fisher atau menggunakan 
ujian chi-square untuk membandingkan masa yang diambil pada tahun 1997 dan 
1998. p<0.05 telah eli ambil sebagai signifikan secara statistik. 
KEPUTUSAN 
Keputusan daripada kajian ini menunjukkan pengunaan Sreptokinase untuk 
pesakit serangan jantung akut boleh dimulakan di jabatan kecemasan. 
Menurut kajian ini, keputusan yang diperoleh ialah:-
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1 . Masa yang diatnbil untuk memulakan streptokinase pada tahun 1997 iaitu 
selruna 38 tninit telah berjaya diperbaik pada tahun 1998 iaitu selatna 26 minit 
saltaja. Ini adalalt statistik signjfikan dengan p<0.05 
2. Pesakit serangan jantung lelaki adalah lebih rrunai daripada pesakit serangan 
jantung perempuan. Terdapat 122 pesakit lelaki rnenakala pesakit perempuan hanya 
11 orang dan peratusanya pula ialah 91.7% berbanding 8.3%. 
3. Berbanding pesakit berbangsa Cina, pesakit berbangsa India adalah lebih ramai 
tnengidap penyakit serangan jantung. Ini kerana, di Malaysia hanya terdapat 7% 
penduduk India dan peratusan kejadian serangan jantung ini adalah lebih tinggi, 
berbanding perah1san penduduk Melayu dan penduduk Cina yang mengidap 
penyakit yang sama. 
4. Komplikasi yang paling banyak berlaku ialah gangguan perjalanan jantung dan 
diikuti pendarahan yang sedikit. Katni telah menyaksikan satu kematian yang 
berlaku serta-merta selepas streptokinase dimulakan. Walau bagaimanapun, tiada 
kejadian angin alunar yang berlaku dalam kes-kes ini. 
KESIMPULAN 
Berdasarkan keputusan kajian ioi, berikut adalah beberapa panduan yang 
telah dicadangkan:-
1 . Streptokinase boleh digunakan untuk merawat serangan janhmg di jabatan 
kecetnasan. 
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2. Adalah lebih baik untuk rne1nulakan streptokinase di hospital daerah terlebih dahulu 
sebehun dirujuk ke hospital yang Jebih besar. 
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ABSTRACT 
ACUTE MYOCARDIAL INF ARCliON : A STUDY OF 
DOOR-TO-NEEDLE TIME OF THROMBOLYTIC THERAPY 
OBJECTIVES 
The objectives of this study were firstly to show that it is possible to start 
throtnbolytic therapy for acute tnyocardial infarction in the Etnergency Departlnent, 
Hospital Kuala Lumpur and probably in other emergency departments of other 
hospitals in the cotmtry. Secondly to show that the door to needle titne is shorter if 
we were to start the thrombolytic therapy in the emergency department rather than 
in the coronary care tmit ward. Thirdly that there would be an improvement in the 
door to needle time in the management of acute tnyocardial infarct in the 
etnergency depart:Inent once the staff of the departtnent had tnore experience. 
METHODS 
l11e study in 1997:1 where all patients who were diagnosed as acute 
tnyocardial infarct were started on streptokinase except in cases during the 
admission days of Universiti Kebangsaan Malaysia, in which the pennission was 
not given. In 1997 we had 67 patients and in 1998 we did the study until July as we 
had gathered 66 patients. 
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The door- to- needle time of starting thrombolytic therapy was calculated 
from the time of registration of the patients till the time the patient was started on 
streptokinase. All the names of the patients were recorded by the staff nurses in the 
special registration book specifically opened for these cases. All cases of acute 
myocardial infarction was treated and observed in the resuscitation zone in the 
Emergency Department Hospital Kuala Lumpur before being sent to the coronary 
care unit ward which is in the fourth floor of the hospital. Besides recording the 
door to needle time we also recorded the name, race, sex and age of the patients, 
We also recorded the early complications of the thrombolytic therapy in the 
emergency department and also when the patient is in the coronary care unit. 
The data was analysed using Fisher's exact test or chi-square test comparing 
the door to needle time in 1997 and 1998 and statistical significance was taken as 
p<0.05. 
RESULTS 
The results of this study showed that thrombolytic therapy for acute 
myocardial infarct could be started in the emergency department 
From this study, it was found out that:-
1. The door to needle time was 38 minutes in 1997 and in 1998 it improved to 
26 minutes. It was statistically significant with a p value less than 0.05. 
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2. Males outnumber females in the number of acute myocardial infarct. 
There were 122 male patients compared to 11 female patients and the 
percentage was 91.7% compared to 8.3%. 
3. The number of patients of Indian origin with acute myocardial infarct was 
more compared to the Chinese. Comparing to the population of Malaysia, 
in which the Indians only comprised of 7% of the population, the incidence 
of acute myocardial infarct was relatively high compared to the Malays 
and the Chinese. 
4. Complications did occur, the commonest was dysrthymia, followed by 
minor bleeding~ we saw one death immediately after starting streptokinase. 
No stroke was seen in cases where we started streptokinase. 
CONCLUSION 
Based on the results of this study, the following guidelines have been 
proposed:-
1. It IS possible to start thrombolytic therapy 1n acute myocardial 
infarction in the emergency department. 
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2. It is better to start thrombolytic therapy in the smaller hospitals than 
transferring the case to bigger hospitals before starting thrombolytic 
therapy. This is to shorten the symptom-to-needle time. 
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CHAPTER 1;- INTRODUCTION 
Acute myocardial infarction is the most intensively studied medical intervention 
in the history of clinical investigations. In this study, besides comparing the door- to-
needle time of starting streptokinase in the emergency department, discussion will be 
made on the current concept of acute myocardial infarction with regards to the 
epidemiology, anatomy, pathophysiology, therapeutics, diagnosis and the current 
management. In the diagnosis, which at times may be difficult, discussion will be 
made regarding electrocardiogram, biochemical markers and cardiac imaging that 
can be done at the emergency department. To understand better the overall picture of 
patient presenting with acute chest pain to the emergency department refer to the 
figure i. 
Acute chest pain 
ECG, history, cardiac enzymes, physical examination 
Acute myocardial infarction 
~ 
Management (Analgesics, aspirin, nitroglycerin, thrombolysis) 
Figure i. General approach of patient presenting with acute chest pain in the 
emergency department. 
The diagnosis of acute myocardial infarction depends on the typical histocy, 
ECG and cardiac enzymes or markers. To make the diagnosis of acute myocardial 
infarction, at least two out of the three of the above features must be present 
The symptoms of ischemic heart disease include chest discomfort, often 
described as chest pressure, heaviness, tightness, fullness or squeezing. The classic 
location is substernal or in the left chest. Radiation to the arm and neck, or jaw may 
occur. In addition, the presence of associated symptoms such as nausea, vomiting, 
diaphoresis, dyspnea, light-headedness, syncope, and palpitations may be useful. The 
chest pain of acute myocardial infarction is more severe and prolonged usually more 
than 30 minutes. Atypical presentations or silent myocardial ischemia are common. 
Physical examination is not helpful in distinguishing patients with acute coronary 
syndromes from those with non cardiac chest pain syndromes. In the standard 12-
lead ECG, the ST -segment is elevated in approximately 50% in acute myocardial 
infarction. (Braunwald E, et al, 1994, Jayes RL et al, 1992, Lee T, et al1985). Most 
patients with acute myocardial infarction will have some nondiagnostic 
abnormalities on the ECG. (Lee T, et al, 1985). Some 1 to 5 percent of patients with 
·acute myocardial infarction has an entirely normal ECG. (Lee T, et al, 1985,Selker 
HP, et all997,Slater DK, et al, 1987, Brush JE, et al, 1985). Newer cardiac enzymes 
or markers will play more prominent role in future, taking over the current "gold 
standard" of creatine kinase M- band (CK-MB). These includes troponin I and T and 
myoglobin when in combination will have greater specificity and sensitivity. 
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hour of symptom onset. It is disappointing therefore in the urban setting in Scotland 
that only 27% (GREAT Group 1992) of patients were admitted to the hospital within 
one hour of onset of symptom and is definitely worst in the rural settings. Using data 
from United Kingdom heart attack study, it has been estimated that 107per1000 
(Sayer JW et al, 2000) lives were saved when they come to hospital within the first 
hour of symptom onset, compared with 21/1000 (J.W. Sayer et al, 2000) for those 
delayed more than 12 hours. As a strategy for saving lives, therefore early access to 
defibrillation is potentially more effective than fron1 thrombolysis especially given 
th3;t, in many centres only about 50% of patient with acute myocardial infarction are 
eligible for thrombolytic therapy. 
To achieve the international standard of door-to-needle time of 60 minutes is 
almost impossible. The 60 minutes of door-to-needle time is used by the Australian 
Council on Healthcare Standards (ACHS) as a national clinical indicator. (Ralk E 
1998). There are a number of difficult obstacles, which need to be tackled before we 
can achieve a target of 60 minutes. First and foremost, the patient must recognise, 
that the symptom is quite serious and he needs immediate attention. He or she needs 
transport to the nearest emergency department. It will save a lot of time if well-
equipped ambulances are available immediately to transport and treat him on the 
way to the hospital. The paramedics in the ambulance must be able to treat the 
complications if it occur in the ambulance on the way to the hospital. In the 
emergency department, the staff must be able to triage him immediately to the 
resuscitation zone and streptokinase started itnmediately once the diagnosis of acute 
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myocardial infarction has been made and there in no contraindications of using 
streptokinase. 
Previously the door- to- needle time was longer as the streptokinase can only 
be administered in the coronary care unit. In fact, studies that has been done in some 
hospitals in United Kingdom, showed that on the average, the door-to-needle time 
was about 80 minutes (Pell ACetal 1992). In this study in which, the streptokinase 
was started in the emergency department, the door-to-needle time was shorter and it 
would be shown that once the emergency department has started treating acute 
myocardial infarction with streptokinase the door to needle time could be reduced 
further. The current acceptable of door-to-needle time is 30 minutes and this can be 
reduced further to 15 minutes. This target could be achieved if the doctors and staff 
remain in the department, but this is not always the case, but continuous training and 
supervision must be continued with regards of administering streptokinase in acute 
myocardial infarction to all staff of the emergency department. The director of the 
hospital should monitor all the time. In Hospital Kuala Lumpur, the weekly report of 
the door-to-needle time was sent to him. (Appendix 2). The decision to start the 
thrombolytic therapy should be the responsibility of the doctors working in the 
resuscitation zone in the emergency department of the hospital and they should be a 
senior doctor, possibly a registrar. The etnergency department should not depend on 
other departments to decide and start the streptokinase as they may not be available 
immediately. 
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The treatment for acute myocardial infarction should be started as soon as 
possible. To make it possible, the community must be educated with regard to the 
symptoms of acute myocardial infarction, and the need for the patient to be at the 
hospital as soon as possible. To educate the public is not difficult nowadays as the 
mass media, such as newspapers, radio, television and the internet can be used. 
It is much better if the community can be provided with a well-equipped and 
efficient ambulance service, which can provide early treatment of acute myocardial 
infarction as well as starting the thrombolytic therapy. The ambulance should also be 
equipped with telemedicine service so that the paramedic can consult with the 
hospital staff if they encounter problems, which they cannot handle. Air ambulance 
if available can also cut down the time. 
In Holland, (BMJ1998) the ambulance service does provide thrombolytic 
therapy at the patient home, and later transfer patient to the hospital. This is the best 
method to cut the time of starting thrombolytic therapy from the onset of symptoms. 
At the moment our ambulance service is not efficient and well-equipped compared to 
other developed countries. Hopefully, in a few years time we will have enough 
trained paramedic to run ambulances which should be well- equipped at the same 
time have telemedicine facilities which not only be able to treat acute myocardial 
infarct but any other serious illnesses. 
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Hospital Kuala Lumpur is among the first hospital in the world and in 
Malaysia to start thrombolytic therapy in the emergency department. The emergency 
department first started the treatment in 1997, but even then, it was late. In fact that 
the then Director-General of Health had proposed the administration of 
streptokinase, in the emergency department four years earlier but due to some 
unforeseen circumstances the emergency department were not able to start the 
service at the time. 
Besides comparing the door-to-needle time between 1997 with 1998, we 
\vere also looking at the age, sex, and race of acute myocardial infarction patients. 
We were also looking at the complications that occur within the first few hours of 
treatment. 
It is hoped with the result of this study, the Ministry of Health can be 
convinced that starting thrombolytic therapy in the emergency department is faster, 
effective and safe. We should start thrombolytic therapy in the emergency 
department of all rrtajor hospitals. If the thrombolytic therapy can be started in the 
emergency department in major hospitals, there is no reason why small district 
hospitals cannot start thrombolytic therapy in the hospital itself instead of sending 
such patients to the nearest bigger hospitals. This of course would certainly reduce 
the time in starting streptokinase in acute myocardial infarction, thus reducing 
morbidity and mortality. 
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CHAPTER 2:- OBJECTIVES OF STUDY 
The objectives of this study are firstly to show that it is possible to start 
thrombolytic therapy for acute myocardial infarction in the Emergency Department 
Hospital Kuala Lumpur. Secondly, to show that the door-to-needle time is reduced if 
the thrombolytic therapy is started at the emergency department rather than at the 
coronary care utrit. Thirdly there will be an improvement of the door-to-needle time 
in the management of acute myocardial infarction in the emergency department once 
the staff becomes more experience. Fourthly, the complications that occur will be the 
same whether the thrombolytic therapy is started at the emergency department or at 
the coronary care utrit. Finally we will be able to identify the sex, age, race and early 
complications of patients suffering from acute myocardial infarction at the 
emergency department. 
8 
CHAPTER 3:- LITERATURE REVIEW 
3.1 EPIDEMIOLOGY 
Coronary artery disease (CAD) is the number one killer in Malaysia. Thirty 
per cent of medically- related deaths reported in the country in 1998 were caused by 
cardiovascular disease. Statistics showed that 82,356 patients were warded in 
government hospitals in 1998 for cardiovascular problems compare to 58,838 ten 
years previously. There were also 4,248 deaths due to the disease in 1998 compared 
to 4,059 in 1988. (Ministry of Health of Malaysia). 
Global statistics supplied by World Health Organization (WHO) indicates 
that CAD is by far the major killer in almost all developed countries, and emerging 
major problem amongst developing nations. Heart disease has emerged as one of the 
world's biggest killers. It is the main cause of death in developed countries and by 
the year 2020 it is expected to be the leading cause of death in developing countries 
as well (New Sunday Times, 18.9 .2000). 
As observed by the World Heart Federation " CAD is a disease without 
geographic, gender or socio-economic boundaries ". Heart disease is largely 
preventable and controllable. Worldwide ischaemic heart disease is believed to cause 
around 6.3 million deaths annually. Ischaemic heart disease is the leading cause of 
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death in United Kingdom and the United States of America. Over 6 million United 
State citizens have coronary artery disease. There are 4 to 5 million emergency 
department visits for acute chest pain annually in USA. Coronary artery disease 
results in approximately 500,000 deaths annually in the USA (Clinical Medicine, 
1998). The total economic bills are around $100 billion per year. In fact in United 
Kingdom the mortality from coronary heart disease is falling. (British Heart 
Foundation Coronary Heart Disease Statistics 1999). Death is being postponed, not 
prevented .Coronary heart disease will continue to increase up to the year 2020. 
(Murray CJL, Lopez AD 1997). 
In Malaysia, there is a high prevalence rate of Malaysian of Indian origin to 
have coronary artery disease compared to the Malays and the Chinese. In fact, 
Indians has 1. 5 times incidence of ischaemic heart disease compared to the Malays 
(K.hoo K.L et al 1991 ). A higher incidence of ischaemic heart disease has also been 
found in Asian Indians in other parts of the world (Heng et al 2000) .It is attributed 
to the difference in prevalence of risk factors in different races such as diabetes 
mellitus, increase in insulin resistance, central obesity and lower low -density lipid. 
3.2 :NN.A TOMY 
Knowledge of the anatomy of the coronary artery is essential to understand 
the effects of myocardial ischemia and why some complications are more common 
with anterior or inferior wall myocardial infarct. The left coronary artery arises from 
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the ascending aorta in the left sinus of the aortic valve. It courses through 
atrioventricular sulcus on the left side, and divides into left circumflex and left 
anterior descending branch. The left anterior descending branch courses down the 
anterior aspect of the heart around the inferior margin and anastomoses with the 
posterior diagonal branch of the right coronary artery. It is the main blood supply to 
the anterior and septal region of the heart. The circumflex branch continues around 
the atrioventricular sulcus, where it anastomoses with the right coronary artery. It 
supplies to some of the anterior wall and a large portion of the lateral wall of the 
heart. The right coronary artery arises from the right sinus of the aortic valve and 
runs in the atrioventricular sulcus between the right atrium and the right ventricle. It 
gives off a marginal branch near the lower aspect of the heart and terminates as right 
posterior descending artery . The right coronary artery supplies the right side of the 
heart with blood and it provides some perfusion to the inferior aspect of the left 
ventricle through the posterior descending artery. 
The Atrio-Ventricular (AV) conduction system receives blood supply from 
the branch of the right coronary artery and the septal perforating branch of the left 
anterior descending artery, Similarly, both the right bundle branch and the left 
posterior division obtain a dual blood flow from the left anterior descending and 
right coronary artery. 
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3.3 PHYSIOLOGY 
Hypoxia is the reduction of oxygen supply to the tissue despite adequate 
perfusion. Ischemia occurs when there is imbalance between oxygen demand and 
ox-ygen supply. Oxygen supply is influenced by the oxygen carrying capacity of the 
blood and the coronary artery blood flow. The oxygen carrying capacity of the blood 
is determined by the amount of hemoglobin present. 
Coronary artery flow is determined by the diastolic relaxation of the heart 
and vascular resistance. Humoral, neural, metabolic, extravascular compressive 
forces and local autoregulation make up the coronary vascular resistance. 
The platelet response involves adhesion, activation and aggregation. Platelet 
adhesion occurs through the weak platelet interaction with subendothelial adhesion 
molecules such as collagen, fibronates and laminin and the binding of glycoprotein 
1 b receptors to the subendothelial form of von Willebrand factor. Adherent platelets 
are strongly thrombogenic . Lipid- laden macrophages in the plaque core and the 
adventitia of the vessel wall release tissue factor, which stimulates the conversion of 
prothrombin to thrombin. Thrombin, collagen, and the local shear forces are all 
potent platelet activators. Platelet secretes adenosine diphosphate, thromboxane H 
two and serotonin are autostimulating agonist of platelet activation. Activat~d 
platelet glycoprotein Ilb!IIla receptors become cross-linked by fibrinogen on von-
Willebrand factor in the common pathway of platelet aggregation. 
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3.4 THE PATHOPHYSIOLOGY OF ACUTE CORONARY 
SYNDROME 
The thrombosis developing on a culprit coronary atherosclerotic plaque 
causes virtually all-regional acute myocardial infarcts. The very rare exceptions are 
coronary artery dissection, coronary arteritis, coronary emboli, coronary emboli, 
coronary spasm and compression by myocardial bridges. Thrombus is also the major 
initiating factor in unstable angina, particularly when rest pain is recent and when the 
pain isincreasing in severity. Necropsy studies, suggest that a new thrombotic 
coronary event underlie 50 to 70% of sudden death caused by ischemic heart disease. 
(Davies MJ 1992). 
The fully-developed human fobrinolipid plaque designated by American 
Heart Association (AHA) as type IV or type Va has a core lipid surrounded by a 
capsule of connective tissue. The core is an extracellular mass of lipid containing 
cholesterol and its esters. The core is surrounded by numerous macrophages, many 
of which contain abundant intracystoplasmic droplets of cholesterol (foam cells). 
These macrophages are not inert but are highly activated producing procoagulant 
tissue factor and a host of inflamtnatory cell mediators such as tumour-necrosing 
factor alpha, interleukins and metalloproteinases, (Stary H, et al, 1995). 
The early stages of plaque development (AHA type I-III) are not associated 
with evidence of structural damage to the endothelium. Once the plaque formation 
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has progress to stage IV, however structural changes in the endothelium become 
almost universal. Focal areas of endothelium denudation occur over the plaque, 
exposing the underlying connective tissue matrix and allowing a monolayer of 
platelet to adhere to the site. 
Thrombosis over plaque occurs because of two somewhat different processes. 
One is caused by an extension of the process of endothelial denudation, so that large 
areas of the surface of the subendothelial connective tissue of the plaque are 
exposed. Thrombus forms and it is adherent to the plaque surface. This process has 
become known as endothelial erosion. The macrophages are highly activated and 
cause endothelial cell death by apoptosis and also by the production of proteases, 
which cut loose the endothelial cells from their adhesion to the vessel wall. 
The second mechanism for thrombus formation is plaque disruption (rupture 
fissuring) where the plaque cap tears to expose the lipid core to blood in arterial 
lumen. The core areas are highly thrombogenic containing tissue factors, fragment of 
collagen and crystalline surfaces to accelerate coagulation. Thrombus forms initially 
in the plaque itself, which expanded and distorted from within~ the thron1bus may 
then extend into arterial I urn en. 
Plaque disruption like endothelial erosion ts a reflection of enhanced 
inflammatory activity within the plaque. The cap is a dynamic structure within which 
the connective tissue matrix, upon which its tensile strength depends, is constantly 
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being replaced and maintained by the smooth muscle cell. The inflammatory process 
both reduces collagen synthesis by inhibiting the smooth muscle cell and causes its 
death by apoptosis. Macrophages also produce a wide range of metalloproteinases 
capable of degrading all the component of the connective tissue matrix, including 
collagen. These metalloproteinases are secreted into the tissues in an inactive form 
and then activated by plasmin. Metalloproteinase production by macrophages is 
upregulated by inflammatory cytokines such as tumour-necrotising factor alpha. 
Plaque disruption is therefore now seen as an auto-destruct phenomenon associated 
with an enhanced inflammatory activation. 
The relative importance of disruption and erosion as triggers of thrombosis 
may vary from between different patient groups. Disruption is the prodominant cause 
(>85%) of major thrombi in white males with high plasma cocentrations of low 
density lipoprotein(LDL ), and low concentration of high density lipoprotein (HDL ). 
In contrast, in women endothelial erosion is responsible for around 50°/o of major 
thrombi. The distinction between erosion and disruption, is not necessary of major 
clinical importance. Both processes depend on enhanced inflammatory activity 
within the plaque and appear equally responsive to lipid lowering. Disruption has an 
intraplaque component n1ore resistant to fibrinolytic treatment, while in erosion the 
tlrrombus is more accessible. This potential advantage is, however, offset by erosion 
related thrombi tending to occur at sites where the pre-existing stenosis was more 
severe. In women there is also a form of thrombosis caused by endothelial erosion 
over pl_aques, which do not contain lipid or major inflammatory component. This 
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type of disease is rare and arguably distinct from conventional atherosclerosis, and 
may be smoking related. (Burke A et al 1997, Davies M, 1997,Arbustini E et al 
1999). 
Analysis of plaque, which has undergone disruption has been used to 
determine characteristics which may indicate currently stable plaque whose structure 
and cell content makes them likely to undergo thrombosis in the future (vulnerable 
plaques). 
There is widespread unanimity in the belief that these features are: 
1. A large lipid core occupying at least 50% of the overall plaque volume 
2. A high density of macrophages 
3. A low density of smooth muscle cells in the cap. 
4. A high tissue factor content 
5. A thin plaque cap in which the collagen structures is disorganised. 
All of these markers of plaque at future risks are likely to be the direct results 
of macrophages activity, which enlarges the core and thins the cap. (Davies M 1997). 
The risk of any subject with coronary artery disease having a future acute 
event will depend on the number of these vulnerable plaque, which are present, 
rather than on the total number of plaques. Patients, however, vary in the number of 
vulnerable plaques, which are present in the coronary arteries. This variation 
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explains why one individual has a series of infarcts at regular intervals while another 
individual has an infarct without further events for the next 10 to 20 years. 
The thrombi, which occur either in disruption or erosion circumstances, are 
dynamic and evolve in stages. In disruption, the initial stage occurs within the lipid 
core itself and is predominantly formed of platelets. As thrombus begins to protrude 
in the lumen, the fibrin component increases, but any surface exposed to the blood in 
the lumen will be covered by activated platelets and are swept down into the distal 
intramyocardial arteries as microemboli. Thrombus may grow to occlude the arteries 
leading to a final stage in which there is a loose network of fibrin containing a large 
number of entrapped red cells. The third and final stage thrombus may propagate 
distally after the onset of myocardial infarction. The final stage of occlusive 
thrombus has a structure making it very susceptible to either natural or therapeutic 
lysis, but expose the deeper and earlier thrombus, which is more resistant to lysis. 
Episodes of plaque disruption, which are almost entirely associated with 
intraplaque thrombus, are associated with the onset of exacerbation of stable angina 
caused by sudden increase of plaque volume. Thrombi, which project into but do not 
occlude the lumen (mural thrombi), are the basis of unstable angina. The intermittent 
attacks of myocardial ischemia at rest are caused by several potential mechanisms. 
The thrombus may intermittent wax and wane in size and become occlusive for short 
petiods of time. 
17 
There may be intense local vasoconstriction. Many disrupted plaques are 
eccentric, with the retention of an arc of normal vessel wall in which constriction can 
reduce blood flow. Platelet deposition is a known potent stimulus for local smooth 
muscle constriction. Embolisation of platelet aggregates into the intramyocardial 
vascular bed both block smaller arteries in the size range of 50-1 OOum external 
diameter and cause vasoconstriction within the myocardium. Necropsy studies show 
a strong correlation between such platelet thrombi and microscopic foci of myocyte 
necrosis. It is difficult now to perceive why coronary thrombosis was regarded 25 
years ago as an inconstant and irrelevant consequence of acute infarction rather than 
its prime cause. Once angiography was carried out soon after the onset of infarction, 
and it was realised that the subtending artery was totally blocked but spontaneously 
reopened with time in many cases (and that this reopening was accelerated by 
fibrinolytic treatment ), thrombosis was seen as a major causal factor in occlusion. 
Suddenly, the clinical world found thrombi to be both dynamic and important. 
Pathologists had thought that thrombi was important but did realise how dynamic it 
cou]d be. Sequential angiograms taken over some years in patients which chronic 
heart ischaemic disease also changed perceptions. It was realised that a significant 
proportion of thrombotic occlusion causing infarction did not develop at sites where 
there was pre-existing high-grade stenosis, or even a plaque identified at all. Sixty-
eight percent of the occlusions leading to acute infarction were judged to have 
caused less than 50o/o diameter stenosis previously, while only 14% developed on 
high grade stenosis of more than 70% diameter in a recent review of literature. (Falk 
E, et al, 1995). 
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The advent of intravascular ultrasound has confirmed that many stable 
coronary plaques angiograpically invisible because of arterial remodelling. In this 
process, described so well by Glacov, the artery is seen to respond to plaque growth 
by increasing its cross sectional area while retaining normal lumen dimensions. 
Angiography cannot and does not predict the sites and risk of future infarctions. It is 
true that chronic high-grade stenoses do progress to occlude, but this is a slow 
process and is often caused by erosion type thrombosis and is not associated with 
acute infarction due to collateral flow. For example, 24% of lesions occluding more 
than 80% by diameter will progress to chronic total occlusion by five years. (Glagov 
S, Weisenberd E, Zarins C, et al1987). 
The magnitude of episodes of disruption varies widely. At one extreme, the 
plaque has a crack or fissure only, and the large thrombotic response appears out of 
proportion to the stimulus. Such events are easily treated by lysis to give a lumen 
size, which is a little different from the previous state or event taken to be a nonnal 
artery. At the other extreme, a plaque undergoes complete disintegration, occluding 
the lumen with a plaque content and thrombus. Another form is where the artery is 
occluded by the thrombus expanding the plaque from within. These more complex 
types of disruption occlusion will be more likely to respond to primary angioplasty. 
The exact morphology of disrupted plaque causing occlusion cannot, however, be 
determined in vivo by any current methodology. 
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Transmural regional acute myocardial infarction is caused by a coronary 
artery occlusion, which develops over a relatively short time frame of a few hours 
and persists for at least 6-8 hours. The infarcted tissue is structurally suggestive of 
homogenous entity-that is, all the myocardium involved died at around the same 
time. Non-transmural regional infarcts (non-Q wave} have a different structure 
which is built up by the coalescence of many small areas of necrosis of different 
ages. This pattern of necrosis characteristically follows crescendo unstable angina 
and appears to be caused by repetitive episodes of short-lived occlusion or platelet 
embolisation or both. A further factor in limiting the spread of necrosis and 
preserving the subpericardial zone is the existence of prior collateral flow in the 
affected artery. (Braunwald E 1998).· 
The challenge of understanding pathophysiology of unstable angina is the 
wide spectrum of clinical severity. Necropsy studies are inevitably biased toward the 
worst outcome, but within this limitation show unstable angina to be caused by 
disrupted plaques with exposed mural thrombi and retention of antegrade flow in the 
artery. This feature of some antegrade flow is all that separates the vascular lesion of 
unstable angina from that of acute infarction. The persistence of the thrombotic 
process so that it neither progresses to occlude nor resolves to heal represents a 
balance between prothrombotic and antithron1botic factors. Confirmation of plaque 
disruption and thrombosis as the basis of severe unstable angina has come from 
angiography in vivo where type II lesions with irregular overhanging edges and 
intra1uminal filling effects representing thrombus is found. These angiographic 
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appearances are rare in unstable angina. Type II lesions have been shown to be 
disrupted plaques by pathology studies. Angioscopy has directly observed tom 
plaque cap in vivo and intravascular ultrasound has also identified disrupted plaque 
in vivo. Atherectomy studies comparing tissue from plaque thought to be responsible 
for stable and unstable angina have shown very consistent results. 
3.5 ELECTROCARDIOGRAM (ECG) 
The normal myocardium depolarizes from endocardium to epicardium and 
repolarises in the opposite direction. When injured, the myocardium remains 
electrically more positive than the uninjured part at the end of depolarisation. The 
relatively positive potential in this area will result in ST elevation of the ECG leads 
over this area. Conversely, if the electrode is located over the uninjured myocardium 
opposite the injured area ST depression will be noted (reciprocal changes). 
After acute n1yocardial infarct the area of necrosis is electrically silent. The 
resultant forces generated from the myocardium during repolarisation (the QRS 
complex) will be affected by the electrically silent area. Electrodes facing the 
infarcted· area will record and abnormal negative deflection during depolarisation 
(pathological Q-waves ). 
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The standard 12-lead ECG, is the single best test to identify patient with 
acute myocardial infarction upon emergency department presentation. American 
National guideline requires that it be obtained and interpreted within 10 minutes of 
presentation. Although, it is been immediately available test in the emergency 
department, it stills has relatively low sensitivity for the detection of acute 
myocardial infarct. (Lee T, Cook F, Weisberg Metal, 1985). 
The ST -segment is elevated during acute myocardial infarction in 
approximately 50% i.e. half of the patients who presented to the emergency 
department with acute myocardial infarct would not be detected solely on the basis 
of ECG. Many patients with acute myocardial infarct will have some non-diagnostic 
abnormalities in the ECG. Some 1% to 5% of patient with acute myocardial infarct 
has an entirely normal ECG. These figures refer to myocardial infarct, not to angina. 
(Brush JE, et al 1985). 
ST -segment elevation in the distribution should suggest acute transmural 
injury. All inferior waves myocardial infarct should have a right-sided V4 (rV4) 
obtained because ST -segment elevation in rV 4 is highly suggestive of right 
ventricular infarct. In general the more elevated the ST -segments and the more ST-
segments that are elevated, the more extensive the injury is. 
The ECG can also be used to predict the infarct- related vessels. Inferior wall 
infarction can result from occlusion of the left circumflex artery or the right coronary 
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artecy. In the setting of an inferior wall infarction, ST -segment elevation in at least 
one lateral leads (V5, V6, aVL) with an isoelectric or elevated ST-segment in lead I 
is strongly suggestive of left circumflex lesion. The presence of ST -segment 
elevation in lead m greater then that of lead II predicts a right coronary artery 
occlusion. When accompanied by either ST -segment elevation on VI or a VR it 
predicts a proximal a right coronal)' artery occlusion with accompanying right 
ventricular infarction. Reciprocal anterior ST- segment depression in VI through V 4 
is equally prevalent in both. 
The main utility of the ECG is to detect acute myocardial infarction. The 
admission ECG, although excellent for selecting patients for thrombolysis, has a 
diagnostic sensitivity of acute myocardial infarct of 55-75 %. The standard 12-lead 
ECG is useful in cardiovascular risk stratification of patient with acute coronary 
syndromes. It can be used in conjunction with clinical history and cardiac markers to 
determine admission location for such patients. (Lee T, et al1985). 
Novel approaches to the ECG have been proposed in the last decade. A 
continuous 12-lead ECG has been developed that record a new 12-lead ECG monitor 
every 20 seconds. When ST-segment baseline is altered, an alarm is raised and a 
copy of the new ECG is automatically showed or printed. This type of technology 
might be useful for monitoring patients who present with non-acute myocardial 
infarct, acute coronary syndrome for ECG evidence of injury. Because of the cost 
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concern regarding labile ST- segment and T -wave changes from hyperventilation or 
patient movements and lack of Emergency Department based prospective studies, 
continuous 12-lead ECG monitoring has not been recommended for routine used. 
ECG with 15,18 and 22 leads have been studied. The addition ofV4R, V8, and V9, 
increased sensitivity without loss of specificity for the detection of ST segment 
elevation. The addition of V4R through V6R and V7-V9 may lead to increase 
sensitivity but at the cost of decrease specificity. 
There are several clinical conditions where ECG interpretation is difficult. It 
has been shown that in the setting of paced rhythms and the left bundle branch block, 
acute myocardial ischemia can be identified. In the setting of left bundle branch 
block (LBBB), the presence of ST- segment elevation>- 1mm and concordant with 
QRS complex ST segment depression> lmm in lead V1, V2 or V3 suggest acute 
myocardial infarct. ST- segment elevation >5mm and discordant with the QRS 
complex increase the likelihood of acute myocardial infarct, but has poor specificity. 
Any ST segment elevation concordant to the QRS complex predominantly the QRS 
complex was highly specific for acute myocardial infarct, the QRS complex is 
predominantly negative in leads VI to V3. ST segment depression in the leads has 
80% specificity for acute myocardial infarct. (Sgarbossa EB, et al 1996). 
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